ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO989

30 Years of Kidney Biopsy Data in Western Mexico

Session Information

Category: Pathology and Lab Medicine

  • 1800 Pathology and Lab Medicine

Authors

  • Alcantar Vallin, Maria de la Luz, Hospital Civil de Guadalajara Unidad Hospitalaria Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico
  • Lopez, Marisol, Hospital Civil de Guadalajara Unidad Hospitalaria Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico
  • Padilla Armas, Jorge Luis, Hospital Civil de Guadalajara Unidad Hospitalaria Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico
  • Sainz Del Real, Susana Maria De Los Angeles, Hospital Civil de Guadalajara Unidad Hospitalaria Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico
  • Chavez, Jonathan, Hospital Civil de Guadalajara Unidad Hospitalaria Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico
  • Villalvazo Maciel, Estefania, Hospital Civil de Guadalajara Unidad Hospitalaria Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico
  • Aranda, Andres, Hospital Civil de Guadalajara Unidad Hospitalaria Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico
  • Franco Garcia, Martha Karina, Hospital Civil de Guadalajara Unidad Hospitalaria Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico
  • Orozco, Carlos Emiliano, Hospital Civil de Guadalajara Unidad Hospitalaria Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico
  • Cruz Aragon, Fernando, Hospital Civil de Guadalajara Unidad Hospitalaria Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico
  • Navarro Blackaller, Guillermo, Hospital Civil de Guadalajara Unidad Hospitalaria Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico
  • Medina, Ramon, Hospital Civil de Guadalajara Unidad Hospitalaria Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico
Background

A kidney biopsy provides the best opportunity to establish the etiology of the Chronic Kidney Disease (CKD), thereby improving management and predicting prognosis.

Methods

A retrospective study was conducted that included adult patients who underwent renal biopsy between 1990 and 2019, performed by nephrologists in 4 centers in western Mexico and analyzed by 2 nephropathologists.

Results

In the 30 years of study, 1933 kidney biopsies were studied, FSGS was the most frequent finding in 28%, followed by Lupus Nephritis. Table 1. We found predominance of lupus nephritis in women and IgAN in men.

Conclusion

In Western Mexico, FSGS is the most frequent histological findings. In the last two decades, we observed a increase in lupus nephritis, pauci-immune glomerulonephritis and tubulopathies, which could be related to changes in causal factors.
In the last decade we also observed a greater number of kidney graft biopsies, compatible with the increase in the number of kidney transplants performed. We consider that the proportion of the chronic kidney disease burden constituted by glomerulonephritis would be illuminated by dissecting it through a comprehensive epidemiological approach.

Histopathologic Diagnoses
 1990-20002001-20102011-2019
MCD1 (0.9)6 (1.9)49 (4.1)
FSGS28 (25.5)139 (44.8)406 (34)
MN9 (8.2)42 (13.5)84 (7)
IgA/HSP1 (0.9)16 (5.2)104 (8.7)
MPGN/C3GP13 (11.8)25 (8.1)35 (2.9)
Amyloid3 (2.7)4 (1.3)34 (2.8)
Diabetic GS9 (8.2)42 (13.5)84 (7)
LN6 (5.5)38 (12.3)181 (15.2)
Pauci-immune GN2(1.8)3 (1)68 (5.7)
TMA01 (0.3)9 (0.8)
DDD001 (0.1)
C1q N01 (0.3)6 (0.5)
Nodular GS02 (0.6)6 (0.5)
Proliferative Mesangial GN (NOS)42 (38.2)18 (5.8)2 (0.2)
Post infectious GN1 (0.9)2 (0.6)7 (0.6)
Tubulointerstitial2 (1.8)4 (1.3)71 (5.9)
ATN02 (0.6)66 (5.5)
Deposition006 (0.5)
Inespecific005 (0.5)